Stocks News

LAST PRICE
30.6100
TODAY'S CHANGE (%)
Trending Down-0.5200 (-1.6704%)

Bid / Lots
29.3000/ 1
Ask / Lots
33.0000/ 3
Open / Previous Close
31.2500 / 31.1300
Day Range
Low 29.7250
High 31.2900
52 Week Range
Low 10.2700
High 47.4500
Volume
469,452
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 26, 2024
- RBC Initiates Dyne Therapeutics at Outperform, Speculative Risk With $45 Price Target, from 6:22AM ET on Tuesday Nov 26, 2024 by MT Newswires
  6:22AM ET on Tuesday Nov 26, 2024 by MT Newswires
  Companies Mentioned: DYN
  06:22 AM EST, 11/26/2024 (MT Newswires) -- Dyne Therapeutics (DYN) has an average rating of buy and mean price target of $50.82, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from major banks a...
- DJ Dyne Therapeutics Initiated at Outperform by RBC Capital, from 5:12AM ET on Tuesday Nov 26, 2024 by Dow Jones
  5:12AM ET on Tuesday Nov 26, 2024 by Dow Jones
  Companies Mentioned: DYN
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/DYN/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 26, 2024 05:12 ET (10:12 GMT)
Nov 13, 2024
- DJ Dyne Therapeutics Is Maintained at Buy by Chardan Capital, from 6:43PM ET on Wednesday Nov 13, 2024 by Dow Jones
  6:43PM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: DYN
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/DYN/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 13, 2024 18:43 ET (23:43 GMT)
- DJ Dyne Therapeutics Price Target Maintained With a $55.00/Share by HC Wainwright & Co., from 9:45AM ET on Wednesday Nov 13, 2024 by Dow Jones
  9:45AM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: DYN
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/DYN/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 13, 2024 09:45 ET (14:45 GMT)
Nov 12, 2024
- Dyne Therapeutics' Q3 Loss Narrows, from 9:11AM ET on Tuesday Nov 12, 2024 by MT Newswires
  9:11AM ET on Tuesday Nov 12, 2024 by MT Newswires
  Companies Mentioned: DYN
  09:11 AM EST, 11/12/2024 (MT Newswires) -- Dyne Therapeutics (DYN) reported a Q3 net loss Tuesday of $0.96 per diluted share, narrowing from a loss of $0.99 a year earlier. Analysts surveyed by Capital IQ expected a loss of $0.71. The company did no...

Nov 27, 2024
- DJ Edgewise Therapeutics Is Maintained at Buy by Truist Securities, from 12:10PM ET on Wednesday Nov 27, 2024 by Dow Jones
  12:10PM ET on Wednesday Nov 27, 2024 by Dow Jones
  Companies Mentioned: EWTX
- Truist Raises Price Target on Edgewise Therapeutics to $50 From $33, Keeps Buy Rating, from 7:33AM ET on Wednesday Nov 27, 2024 by MT Newswires
  7:33AM ET on Wednesday Nov 27, 2024 by MT Newswires
  Companies Mentioned: EWTX
Nov 26, 2024
- Iovance Biotherapeutics Names Raj Puri as Chief Regulatory Officer, from 4:54PM ET on Tuesday Nov 26, 2024 by MT Newswires
  4:54PM ET on Tuesday Nov 26, 2024 by MT Newswires
  Companies Mentioned: IOVA
- Press Release: Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer, from 4:01PM ET on Tuesday Nov 26, 2024 by Dow Jones
  4:01PM ET on Tuesday Nov 26, 2024 by Dow Jones
  Companies Mentioned: IOVA
- Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer, from 4:01PM ET on Tuesday Nov 26, 2024 by Dow Jones
  4:01PM ET on Tuesday Nov 26, 2024 by Dow Jones
  Companies Mentioned: IOVA
- SpringWorks Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference, from 7:00AM ET on Tuesday Nov 26, 2024 by Dow Jones
  7:00AM ET on Tuesday Nov 26, 2024 by Dow Jones
  Companies Mentioned: SWTX
- Edgewise Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference on December 3, 2024, from 6:00AM ET on Tuesday Nov 26, 2024 by Dow Jones
  6:00AM ET on Tuesday Nov 26, 2024 by Dow Jones
  Companies Mentioned: EWTX
Nov 22, 2024
- Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:05PM ET on Friday Nov 22, 2024 by Dow Jones
  4:05PM ET on Friday Nov 22, 2024 by Dow Jones
  Companies Mentioned: VERA
- DJ Edgewise Therapeutics Initiated at Outperform by Evercore ISI Group, from 9:53AM ET on Friday Nov 22, 2024 by Dow Jones
  9:53AM ET on Friday Nov 22, 2024 by Dow Jones
  Companies Mentioned: EWTX
Nov 21, 2024
- DJ Vera Therapeutics Initiated at Overweight by Wells Fargo, from 8:14AM ET on Thursday Nov 21, 2024 by Dow Jones
  8:14AM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: VERA

Dyne Therapeutics Inc
NASDAQ:DYNUnited States

Search Criteria

Nov 26, 2024

RBC Initiates Dyne Therapeutics at Outperform, Speculative Risk With $45 Price Target, from 6:22AM ET on Tuesday Nov 26, 2024 by MT Newswires

DJ Dyne Therapeutics Initiated at Outperform by RBC Capital, from 5:12AM ET on Tuesday Nov 26, 2024 by Dow Jones

Nov 13, 2024

DJ Dyne Therapeutics Is Maintained at Buy by Chardan Capital, from 6:43PM ET on Wednesday Nov 13, 2024 by Dow Jones

DJ Dyne Therapeutics Price Target Maintained With a $55.00/Share by HC Wainwright & Co., from 9:45AM ET on Wednesday Nov 13, 2024 by Dow Jones

Nov 12, 2024

Dyne Therapeutics' Q3 Loss Narrows, from 9:11AM ET on Tuesday Nov 12, 2024 by MT Newswires

Peers Headlines

Nov 27, 2024

DJ Edgewise Therapeutics Is Maintained at Buy by Truist Securities, from 12:10PM ET on Wednesday Nov 27, 2024 by Dow Jones

Truist Raises Price Target on Edgewise Therapeutics to $50 From $33, Keeps Buy Rating, from 7:33AM ET on Wednesday Nov 27, 2024 by MT Newswires

Nov 26, 2024

Iovance Biotherapeutics Names Raj Puri as Chief Regulatory Officer, from 4:54PM ET on Tuesday Nov 26, 2024 by MT Newswires

Press Release: Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer, from 4:01PM ET on Tuesday Nov 26, 2024 by Dow Jones

Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer, from 4:01PM ET on Tuesday Nov 26, 2024 by Dow Jones

SpringWorks Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference, from 7:00AM ET on Tuesday Nov 26, 2024 by Dow Jones

Edgewise Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference on December 3, 2024, from 6:00AM ET on Tuesday Nov 26, 2024 by Dow Jones

Nov 22, 2024

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:05PM ET on Friday Nov 22, 2024 by Dow Jones

DJ Edgewise Therapeutics Initiated at Outperform by Evercore ISI Group, from 9:53AM ET on Friday Nov 22, 2024 by Dow Jones

Nov 21, 2024

DJ Vera Therapeutics Initiated at Overweight by Wells Fargo, from 8:14AM ET on Thursday Nov 21, 2024 by Dow Jones